Skip to content Skip to footer
Subscribe Now

TOP 20

Generics Pharma Companies Top 20 2020
Top 20 Generics Pharma Companies Based On 2020 Revenue
Shots: Generic medicines are the backbone of the healthcare system and are identical to the innovator medicine in strength- effect- dosage form- and route of administration. These are allowed for sale after the patent expiry of the original drugs Our team at PharmaShots has compiled a list of the top 20 generic companies based on…
October 28, 2021
Oncology Companies Based Top 20 2020
Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue
Oncology is a rapidly evolving therapy area and all of the top Biopharma players are investing in the research and development of cancer therapies. In 2020- the world witnessed a major acquisition of Immunomedic by Gilead of $21B for Trodelvy Our team at PharmaShots has compiled a list of top 20 oncology companies based on…
September 9, 2021
Immunology Companies Based Top 20 2020
Top 20 Immunology Companies Based on 2020 Immunology Segment Revenue
Immunology deals with the physiological functioning of the immune system in states of both health and disease as well as malfunctions of the immune system in immunological disorders With the new advancement in the immune sector- global pharmaceuticals continue to grow in the field despite the disruption during COVID-19. As in 2019- Abbvie again secured…
August 12, 2021
Innovative Digital Therapeutics Top 20 2020
Top 20 Innovative Digital Therapeutics Companies of 2020
The digital therapeutics market has unsurprisingly exploded in last few years. Available virtually- digital therapies are developed by engineers- clinicians & scientists and are rigorously tested- making it possible for people to access treatment for both physical & psychological conditions at home Demand for digital therapies has skyrocketed amid the COVID-19 pandemic. As a result-…
July 8, 2021
Diagnostics Companies Top 20 2020
Top 20 Diagnostics Companies Based on 2020 Revenue
The extraordinary demand for COVID-19 testing kits that were seen in 2020 and is yet to subside in 2021 resulted in many of the world's biggest diagnostics companies being thrust into the limelight Siemens Healthineers- GE Healthcare- Roche- and Abbott are the top players in the race of the global diagnostic companies. The companies are…
June 10, 2021
Medical Device Companies Top 20 2020
Top 20 Medical Device Companies Based on 2020 Revenue
The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020- the companies have shown growth resulting from a rise in the number of healthcare facilities- healthcare expenditure- and technological advancements. Medtronic remains at the top…
May 20, 2021
BioPharma Companies Top 20 2020
Top 20 BioPharma Companies based on 2020 Total Revenue
Despite having the global Covid-19 pandemic- the biopharma companies were involved in multiple M&A and licensing deals. The major focus of the year remains the production and distribution of vaccines to combat the COVID-19 globally All of the Biopharma companies on our list are on the front line to combat this global crisis. The top…
April 8, 2021
Biopharma Deal Terminations Top 20 2020
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
The biopharma industry saw numerous deal terminations in 2020. Clinical and regulatory results- change in control limitations- and strategic reprioritizations were among the most common reasons for deal termination. Sanofi and Hanmi's agreement in 2015 ranked first under which Hanmi regained WW rights to its protein/peptide discovery technology- lapscovery. The second position goes to the…
February 11, 2021
Life Sciences Deals Top 20 2020
Top 20 Life Sciences Deals of 2020 by Total Deal Value
Life sciences companies are gearing up to enter new markets as they look to secure their positions after a spate of M&A- licensing- and research partnerships in 2020 Artios partnered with Merck with an option to license up to 8 oncology programs proving to be the highest valued deal of 2020 with a total deal…
January 22, 2021
Biopharma M&A Top 20 2020
Top 20 Biopharma M&A of 2020 by Total Deal Value
Biopharma merger and acquisition activity in 2020 was mainly filled with late-stage- bolt-on acquisitions- which were orders of magnitude smaller than the mega M&A deals of prior years. AstraZeneca holds the top rank by acquiring Alexion Pharmaceuticals among the top 20 acquisitions with a total deal value of $39B at a 1-day premium of 45%…
January 7, 2021
Load more